Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
0.641
-0.059 (-8.41%)
At close: Oct 22, 2024, 4:00 PM
0.661
+0.020 (3.10%)
After-hours: Oct 22, 2024, 5:10 PM EDT
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $2.86 million as of October 23, 2024. Its market cap has decreased by -42.72% in one year.
Market Cap
2.86M
Enterprise Value
1.94M
1-Year Change
-42.72%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since December 2, 2010, Protagenic Therapeutics's market cap has decreased from $10.30M to $2.86M, a decrease of -72.19%. That is a compound annual growth rate of -8.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2024 | 3.10M | -29.55% |
Dec 29, 2023 | 4.40M | -36.23% |
Dec 30, 2022 | 6.90M | -70.64% |
Dec 31, 2021 | 23.50M | 115.60% |
Dec 31, 2020 | 10.90M | -24.83% |
Dec 31, 2019 | 14.50M | -29.27% |
Dec 31, 2018 | 20.50M | -9.29% |
Dec 29, 2017 | 22.60M | -45.54% |
Dec 30, 2016 | 41.50M | 41,400.00% |
Dec 31, 2015 | 100.00K | -80.00% |
Dec 31, 2014 | 500.00K | - |
Dec 31, 2013 | - | - |
Dec 31, 2012 | - | -100.00% |
Dec 30, 2011 | 100.00K | -99.39% |
Dec 31, 2010 | 16.40M | 59.22% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tharimmune | 2.52M |
Phio Pharmaceuticals | 2.50M |
Xylo Technologies | 2.50M |
ZyVersa Therapeutics | 2.47M |
Ensysce Biosciences | 2.47M |
Galmed Pharmaceuticals | 2.45M |
Allarity Therapeutics | 2.44M |
Dermata Therapeutics | 2.43M |